FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

412519000: Terazosin hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2693243019 Terazosin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3047090017 Terazosin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
20241000188110 térazosine chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
844331000172116 chlorhydrate de térazosine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terazosin hydrochloride Is a Terazosin (substance) false Inferred relationship Some
Terazosin hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alpha-1 adrenergic receptor antagonist (disposition) true Inferred relationship Some
Terazosin hydrochloride Is a allergène médicamenteux false Inferred relationship Some
Terazosin hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Terazosin (substance) true Inferred relationship Some
Terazosin hydrochloride Is a Alpha-1 adrenergic receptor antagonist true Inferred relationship Some
Terazosin hydrochloride Is a Alpha adrenergic receptor antagonist false Inferred relationship Some
Terazosin hydrochloride Is a Vasodilator (substance) true Inferred relationship Some
Terazosin hydrochloride Is a Autonomic agent (substance) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Terazosin hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Terazosin hydrochloride 10mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Terazosin hydrochloride 5mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Terazosin hydrochloride 2mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Terazosin (as terazosin hydrochloride) 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Terazosin (as terazosin hydrochloride) 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Terazosin (as terazosin hydrochloride) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some
Terazosin (as terazosin hydrochloride) 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 2 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 1 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 1 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Terazosin hydrochloride Inferred relationship Some 1
Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 5 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Terazosin hydrochloride Inferred relationship Some 1
Terazosin (as terazosin hydrochloride) 10 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Terazosin hydrochloride Inferred relationship Some 1
Terazosin hydrochloride dihydrate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Terazosin hydrochloride Inferred relationship Some
Terazosin hydrochloride anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Terazosin hydrochloride Inferred relationship Some

This concept is not in any reference sets

Back to Start